Lobbying activity

Q4

TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Medicare/Medicaid, Health Issues

View → Q4

TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q4

BGR GOVERNMENT AFFAIRS for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

HARMONY BIOSCIENCES for HARMONY BIOSCIENCES

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate

Pharmacy

View → Q4

FORBES-TATE for IONIS PHARMACEUTICAL, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q4

FORBES-TATE for NOVARTIS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations

View → Q4

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid

View → Q4

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Budget/Appropriations

View → Q4

PUBLIC CITIZEN for PUBLIC CITIZEN

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products

View → Q4

TROUTMAN STRATEGIES for THE MENDED HEARTS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $60,000.00 income

Health Issues

View → Q4

LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income

Health Issues

View → Q4

LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $70,000.00 income

Medicare/Medicaid

View → Q4

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate

Health Issues

View → Q4

VENABLE LLP for ASSOCIATION OF BLACK CARDIOLOGISTS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $30,000.00 income

Health Issues

View → Q3

TODD STRATEGY GROUP for NOVARTIS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q3

TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → Q3

SPLITOAK STRATEGIES LLC for ALNYLAM PHARMACEUTICALS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income

Medicare/Medicaid

View → 2A

AMGEN, INC. for AMGEN INC

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q3

AMGEN, INC. for AMGEN INC

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q3

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q3

NOVARTIS for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → 3T

THE MCMANUS GROUP for ALNYLAM PHARMACEUTICALS

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $20,000.00 income

Medicare/Medicaid

View → Q3

BGR GOVERNMENT AFFAIRS for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid

View → Q3

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid

View →